Airline Access to Emergency Epinephrine
The Airline Access to Emergency Epinephrine Act, S.1972 would require airlines to store/stock epinephrine auto-injectors on an aircraft within 180 days and have flight attendants administer it in the event of an emergency. The legislation would also ensure that flight attendants are trained to identify and respond to life-threatening anaphylactic reactions. Moreover, the measure instructs Federal Aviation Administration and individual airlines to clarify within 30 days that the epinephrine vials currently included in emergency medical kits are intended to be used for the treatment of anaphylaxis. The bill directs the U.S. Government Accountability Office (GAO) to study and generate a national report that will explore the incidence of in-flight reactions and emergency landings, costs of emergency landings, and the resources required to develop model accommodation policies.
Allergy & Asthma Network supports the Airline Access to Emergency Epinephrine Act and urges members to contact their Congressional Representatives about it.